Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized …
BACKGROUND: Patients with heart failure (HF) are at high risk for mortality and
rehospitalization in the early period after hospital discharge. We developed clinical models …
rehospitalization in the early period after hospital discharge. We developed clinical models …
Extent, location, and clinical significance of non–infarct-related coronary artery disease among patients with ST-elevation myocardial infarction
DW Park, RM Clare, PJ Schulte, KS Pieper, LK Shaw… - Jama, 2014 - jamanetwork.com
Importance Little information exists about the anatomical characteristics and clinical
relevance of non–infarct-related artery (IRA) disease among patients with ST-segment …
relevance of non–infarct-related artery (IRA) disease among patients with ST-segment …
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study
GM Felker, M Fiuzat, LK Shaw, R Clare… - Circulation: heart …, 2012 - Am Heart Assoc
Background—Galectin-3 is a soluble ß-galactoside–binding lectin released by activated
cardiac macrophages. Elevated levels of galectin-3 have been found to be associated with …
cardiac macrophages. Elevated levels of galectin-3 have been found to be associated with …
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event …
M Valgimigli, F Costa, Y Lokhnygina… - European heart …, 2017 - academic.oup.com
Aims Dual antiplatelet therapy reduces non-fatal ischaemic events after acute coronary
syndrome (ACS) but increases bleeding to a similar extent. We sought to determine the …
syndrome (ACS) but increases bleeding to a similar extent. We sought to determine the …
[HTML][HTML] Analyses of cancer data from three ezetimibe trials
R Peto, J Emberson, M Landray… - … England Journal of …, 2008 - Mass Medical Soc
Background Five years of statin therapy lowers low-density lipoprotein (LDL) cholesterol
substantially and, over a 5-year period, results in reductions in the incidence of …
substantially and, over a 5-year period, results in reductions in the incidence of …
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial
SG Goodman, R Clare, KS Pieper, JC Nicolau… - Circulation, 2012 - Am Heart Assoc
Background—The clinical significance of the interaction between clopidogrel and proton
pump inhibitors (PPIs) remains unclear. Methods and Results—We examined the …
pump inhibitors (PPIs) remains unclear. Methods and Results—We examined the …
6-min walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure
DE Forman, JL Fleg, DW Kitzman, CA Brawner… - Journal of the American …, 2012 - jacc.org
Objectives: The goal of this study was to compare the prognostic efficacy of the 6-min walk
(6MW) and cardiopulmonary exercise (CPX) tests in stable outpatients with chronic heart …
(6MW) and cardiopulmonary exercise (CPX) tests in stable outpatients with chronic heart …
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in …
BH Greenberg, WT Abraham, NM Albert, K Chiswell… - American heart …, 2007 - Elsevier
BACKGROUND: Diabetes, a common comorbidity in patients with heart failure (HF), is
associated with worse long-term outcomes in patients with HF due to systolic dysfunction …
associated with worse long-term outcomes in patients with HF due to systolic dysfunction …
Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model
CM O'Connor, DJ Whellan, D Wojdyla… - Circulation: Heart …, 2012 - Am Heart Assoc
Background—We aimed to develop a multivariable statistical model for risk stratification in
patients with chronic heart failure with systolic dysfunction, using patient data that are …
patients with chronic heart failure with systolic dysfunction, using patient data that are …
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial
Background PF-00547659 is a fully human monoclonal antibody that binds to human
mucosal addressin cell adhesion molecule-1 (MAdCAM-1) to selectively reduce lymphocyte …
mucosal addressin cell adhesion molecule-1 (MAdCAM-1) to selectively reduce lymphocyte …